About Us
Apinovo’s vision is to catalyze a renaissance in API synthesis and manufacturing
World-class team of corporate executives, research chemists, and scientific advisors
Executive Leadership

Rashmi Barbhaiya, PhD, CEO
- Former VP BMS; President R&D Ranbaxy, Co-founder and CEO Advinus; Serial entrepreneur
- SAB, GARDP – Global Antibiotic Research and Development Partnership; Scientific Advisory Committee of DNDi, a Geneva, Switzerland based organization focusing on neglected diseases; Chair, Advisory Council, Institute for Life Science Entrepreneurship
- Track record of building multiple strategic R&D partnerships with large pharma such as Takeda, Merck, Novartis, J&J and Celgene

Mukund Chorghade, PhD, CSO
- Former VP Genzyme; CSO, THINQ; Chicago Discovery, Empiriko, AGN Biofuels
- Research/Visiting Professor at Harvard, MIT, Princeton, Rutgers, Cambridge, Strathclyde, Univ. of Illinois
- Elected Fellow of ACS, AAAS, RSC, IUPAC
- Won three “Scientist of the Year Awards” in different companies

Thomas Richardson, PhD, COO
- R&D and BD Momenta Pharmaceuticals (JNJ), Medarex (BMS), and President ILSE;
- Extensive experience in licensing, BD and entrepreneurship
- Current President, Institute for Life Science Entrepreneurship; President & CEO, Plumeria Therapeutics Inc.
Scientific Advisory Board

Joseph Fortunak, PhD
- Professor of Chemistry and Pharmaceutical Sciences at Howard University, Washington D.C.
- Contributed to the launch of 15 new drugs and 25+ new generic products with total sales of over $200 billion
- Received numerous awards including the American Chemical Society “Heroes of Chemistry”, and a US FDA Honor Award for Excellence and Innovation in Africa
- Has over 100 publications and 40+ patent applications

Steven Ley, PhD
- BP 1702 Professor of Chemistry, University of Cambridge; Head of Department in 1989
- Elected to the Royal Society (London) in 1990, President of The Royal Society of Chemistry from 2000-2002
- Consultant and advisor to many companies, including Pfizer, Merck, and Syngenta

Robert H. Grubbs, PhD,
Nobel Laureate, Chemistry 2005
- Victor and Elizabeth Atkins Professor of Chemistry at the California Institute of Technology; Inventor of Grubbs Catalyst™ technology; Research on complexes that catalyze basic organic transformations (major focus on the olefin metathesis reaction)
- A founder, director or advisor to numerous technology companies, including Cyrano Sciences, Coelacanth, Pharmacopeia, Insert Therapeutics, Calhoun Vision and
Symyx Technologies